Floatz logo

Allogeneic Cytomegalovirus-Specific Cytotoxic T Lymphocytes

Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia

Fred Hutchinson Cancer CenterCell therapyPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
National Cancer Institute (NCI)
Phase 1/2B
Cediranib
National Cancer Institute (NCI)
Phase 1/2B
Allopurinol
National Cancer Institute (NCI)
Phase 1/2CCC
aciclovir
National Cancer Institute (NCI)
Phase 1/2CCC
Imatinib
National Cancer Institute (NCI)
Phase 1/2CCC

View all 20 →

Same molecule, other indications

Allogeneic Cytomegalovirus-Specific Cytotoxic T Lymphocytes is also rated in:

cytomegalovirus infectionDormant
CCC
Indicative ·
53 / 100
View asset →
hematopoietic and lymphoid cell neoplasmDormant
CCC
Indicative ·
53 / 100
View asset →
cancerDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →